Anti-TR19L/ RELT/ TNFRSF19L monoclonal antibody

Anti-TR19L/ RELT/ TNFRSF19L antibody for FACS & in-vivo assay

Target products collectionGo to RELT/RELT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1457-Ab-1/ GM-Tg-hg-MP1457-Ab-2Anti-Human RELT monoclonal antibodyHuman
GM-Tg-rg-MP1457-Ab-1/ GM-Tg-rg-MP1457-Ab-2Anti-Rat RELT monoclonal antibodyRat
GM-Tg-mg-MP1457-Ab-1/ GM-Tg-mg-MP1457-Ab-2Anti-Mouse RELT monoclonal antibodyMouse
GM-Tg-cynog-MP1457-Ab-1/ GM-Tg-cynog-MP1457-Ab-2Anti-Cynomolgus/ Rhesus macaque RELT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1457-Ab-1/ GM-Tg-felg-MP1457-Ab-2Anti-Feline RELT monoclonal antibodyFeline
GM-Tg-cang-MP1457-Ab-1/ GM-Tg-cang-MP1457-Ab-2Anti-Canine RELT monoclonal antibodyCanine
GM-Tg-bovg-MP1457-Ab-1/ GM-Tg-bovg-MP1457-Ab-2Anti-Bovine RELT monoclonal antibodyBovine
GM-Tg-equg-MP1457-Ab-1/ GM-Tg-equg-MP1457-Ab-2Anti-Equine RELT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1457-Ab-1/ GM-Tg-hg-MP1457-Ab-2; GM-Tg-rg-MP1457-Ab-1/ GM-Tg-rg-MP1457-Ab-2;
GM-Tg-mg-MP1457-Ab-1/ GM-Tg-mg-MP1457-Ab-2; GM-Tg-cynog-MP1457-Ab-1/ GM-Tg-cynog-MP1457-Ab-2;
GM-Tg-felg-MP1457-Ab-1/ GM-Tg-felg-MP1457-Ab-2; GM-Tg-cang-MP1457-Ab-1/ GM-Tg-cang-MP1457-Ab-2;
GM-Tg-bovg-MP1457-Ab-1/ GM-Tg-bovg-MP1457-Ab-2; GM-Tg-equg-MP1457-Ab-1/ GM-Tg-equg-MP1457-Ab-2
Products NameAnti-RELT monoclonal antibody
Formatmab
Target NameRELT
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RELT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TR19L/ RELT/ TNFRSF19L VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1457
    Target NameRELT
    Gene ID84957,320100,361615,718143,485200,101098820,505716,100065672
    Gene Symbol and SynonymsAI3C,E430021K24Rik,RELT,TNFRSF19L,TRLT
    Uniprot AccessionQ969Z4
    Uniprot Entry NameTR19L_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000054967
    Target ClassificationN/A

    The target: RELT, gene name: RELT, also named as TNFRSF19L, TRLT. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is especially abundant in hematologic tissues. It has been shown to activate the NF-kappaB pathway and selectively bind TNF receptor-associated factor 1 (TRAF1). This receptor is capable of stimulating T-cell proliferation in the presence of CD3 signaling, which suggests its regulatory role in immune response. Two alternatively spliced transcript variants of this gene encoding the same protein have been reported. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.